These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8716243)

  • 1. [Blood transfusion and monitoring. Blood products for transfusion. Indications].
    Gaspard M
    Soins; 1996 Apr; (605):18-9. PubMed ID: 8716243
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood component replacement therapy.
    Coffland FI; Sheleton DM
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):543-56. PubMed ID: 8217049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood transfusion.
    Nerlich S
    Aust Nurs J; 1998 Jun; 5(11):suppl i-iv. PubMed ID: 10639966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of blood products.
    McMahon M
    Int J Trauma Nurs; 2000; 6(3):95-100. PubMed ID: 10891848
    [No Abstract]   [Full Text] [Related]  

  • 5. The potential usefulness of thrombelastography in quality monitoring and quality improvement of blood components.
    Seghatchian J
    Transfus Apher Sci; 2009 Dec; 41(3):227-8. PubMed ID: 19800846
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Risk management from the perspective of the hematologist].
    Gossrau E
    Z Arztl Fortbild Qualitatssich; 2003 Nov; 97(8-9):618-21. PubMed ID: 14710657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal blood component therapy.
    Armentrout D; Getz SL
    J Perinat Neonatal Nurs; 1998 Dec; 12(3):50-66. PubMed ID: 10326433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When to administer modified blood products.
    Fitzpatrick L
    Nursing; 2002 May; 32(5):36-41; quiz 42. PubMed ID: 12035651
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for labile blood products].
    Jeanne M; Rasonglès P
    Rev Prat; 2001 Jun; 51(12):1318-27. PubMed ID: 11503505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood products].
    Montloin A
    Rev Infirm; 1992 Mar; 42(6):33-41. PubMed ID: 1598492
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality requirements and quality assurance of leukocyte-depleted blood components.
    Myllylä G
    Curr Stud Hematol Blood Transfus; 1994; (60):111-22. PubMed ID: 8088164
    [No Abstract]   [Full Text] [Related]  

  • 13. Practical aspects of the self-assessment of the issue and administration of blood: a review of two hospitals' experiences.
    Shulman IA; Jones FS
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S17-22. PubMed ID: 9124224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood transfusion: the high-risk life-saving therapy.
    Casey G
    Nurs N Z; 2011 May; 17(4):20-5. PubMed ID: 21736112
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparinized venous approaches].
    Arnáiz Betolaza L; Novoa Vences E
    Rev Enferm; 1996 May; 19(213):64-5. PubMed ID: 8716873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transfusion of blood and products derived from blood].
    Wautier JL
    Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quality assurance in blood transfusion].
    Chevrolle F
    Ann Pharm Fr; 2002 Sep; 60(5):318-25. PubMed ID: 12378141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial contamination of blood products.
    Palavecino E; Jacobs M; Yomtovian R
    Curr Hematol Rep; 2004 Nov; 3(6):450-5. PubMed ID: 15496280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood component therapy in obstetrics.
    Fuller AJ; Bucklin B
    Obstet Gynecol Clin North Am; 2007 Sep; 34(3):443-58, xi. PubMed ID: 17921009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computer-assisted transfusion management system and changed transfusion practices contribute to appropriate management of blood components.
    Ohsaka A; Abe K; Ohsawa T; Miyake N; Sugita S; Tojima I
    Transfusion; 2008 Aug; 48(8):1730-8. PubMed ID: 18482189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.